Komeda Masashi | Department Of Cardiovascular Surgery Kyoto University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Chymase Inhibition Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction in Rats
Chymase Inhibition Attenuates Myocardial Fibrosis and Cardiac Dysfunction after Myocardial Infarction in Rats(Cardiac Function, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
4 Branched Stentgraft and Hybrid Approach for Complex Thoracic and Thoracoabdominal Aortic Aneurysm(Symposium 4 (SY-04) (H) Recent Progress in the Treatment of Aortic Diseases,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation
4 Endovascular Repair with the Inoue Stentgraft for Abdominal and Thoracoabdominal Aortic Aneurysms(Stent-graft for Aortic aneurysms and Dissections:results of clinical application, indication, recent advancement, and future perspective,Meet the Expert 2
Sustained Release of Prostaglandin E_1 Potentiates the Impaired Therapeutic Angiogenesis by Basic Fibroblast Growth Factor in Diabetic Murine Hindlimb Ischemia
New Therapeutic Approach for Impaired Arteriogenesis in Diabetic Mouse Hindlimb Ischemia
A Novel Approach to Therapeutic Angiogenesis for Patients With Critical Limb Ischemia by Sustained Release of Basic Fibroblast Growth Factor Using Biodegradable Gelatin Hydrogel : An Initial Report of the Phase I-IIa Study
PJ-833 Single Intratracheal Administration of Micro Gelatin Hydrogel Microspheres Incorporating bFGF can Ameliorate the Survival of Monocrotaline-induced Pulmonary Hypertension Rats(Pulmonary circulation-4, The 71st Annual Scientific Meeting of the Japane
PJ-687 Local Sustained Release of Vancomycin (VCM) may Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Graft Infection(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-547 Combined Therapy of Basic Fibroblast Growth Factor (bFGF) and Sarpogrelate Enhances Arteriogenesis Efficiently in Diabetic Mouse Hind Limb Ischemia(Peripheral circulation/Vascular disease-4, The 71st Annual Scientific Meeting of the Japanese Circul
4 Control-release of MMP-1 Plasmid DNA Improved Contractility and Altered Na/Ca Exchange of Cardiomyocytes Isolated from Rat Chronic Myocardial Infarction Heart(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
6 Clinical Trials for Ischemic Hearts and Limbs Using Control-released Basic Fibroblast Growth Factor(Clinical Trials of Regeneration Therapy in Japan, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
4 Towards New Era for Regenerative Medicine in Cardiovascular Area(Regeneration Therapy Using Tissue Engineering, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Combined Treatment With Sustained-Release Basic Fibroblast Growth Factor and Heparin Enhances Neovascularization in Hypercholesterolemic Mouse Hindlimb Ischemia
Sustained-Release Erythropoietin Ameliorates Cardiac Function in Infarcted Rat-Heart Without Inducing Polycythemia
Combined Treatment of Sustained-Release Basic Fibroblast Growth Factor and Sarpogrelate Enhances Collateral Blood Flow Effectively in Rabbit Hindlimb Ischemia
PJ-118 Combined Treatment of Sustained-release Basic Fibroblast Growth Factor and Heparin Enhances Angiogenesis in Hypercholesterolemic Mouse Hindlimb Ischemia(Peripheral circulation-8 (H) PJ20,Poster Session (Japanese),The 70th Anniversary Annual Scienti
Control-Release of Insulin-like Growth Factor-1 Enhances the Efficacy of Skeletal Myoblast Transplantation in Chronic Myocardial Ischemia Model (Vasoactive Compound/Growth Factor/Cytokine 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulati
Induction of Arteriogenesis in Chronic Ischemic Myocardium by a Combination of bFGF and Omentopexy as Extra Cardiac Blood Source(Vascular Regeneration (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury : toward safety and minimal invasiveness
Delivery Route in Bone Marrow Cell Transplantation Should be Optimized According to the Etiology of Heart Disease
A Case of Peripartum Cardiomyopathy With Recurrent Left Ventricular Apical Thrombus
Repeated Implantation is a More Effective Cell Delivery Method in Skeletal Myoblast Transplantation for Rat Myocardial Infarction
To Maximize LV Function after the Valve Surgery(Diagnosis and Treatment of Valvular Heart Disease-Multidiciplinary Treatment of the Patients who Suffer from Secondary Heart Failure, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Transplanted Skeletal Myoblasts Can Fully Replace the Infarcted Myocardium and Reverse Left Ventricular Remodeling
Control-Released Hepatocyte Growth Factor (HGF) Prevents Myocardial Fibrosis in Spontaneously Hypertensive Rats
The Regenerated Cardiac Myocytes Derived from Bone Marrow Adult Stem Cells Cultured with Cardiac Condition Medium in Vitro
Basic Fibroblast Growth Factor (bFGF) Released from Biodegradable Gelatin Hydrogel is Protected from Advanced Glycation in Diabetic Limb Ischemia(Angiogenesis 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
PE-064 Metoprolol Helps Maintain Left Ventricle's Function during Mechanical Unloading(Cardiac function, basic/clinical-3 (M) PE11,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
OJ-210 Developing More Effective Surgery for "tough" Atrial Fibrillation (Af) with Large Left Atrial Diameter (LAD) and Long-term Duration(Arrhythmia, therapy-4 (A) OJ35,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Ja
Evidence of Local Aldosterone Production in Patients with Left Ventricular Remodeling : Analysis of Pericardial Fluid at Open Heart Surgery(Heart Failure, Clinical 13 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Developing "Bio-CABG"-Revascularizing Numerous Coronary Branches by the Arterial Graft
5 New Therapeutic Strategy for Ischemic Mitral Regurgitation : Repairing and protecting LV(New Diagnostic and Therapeutic Strategies for Ischemic Mitral Regurgitation,ACC-JCS Joint Symposium (JS1) (IHD),The 70th Anniversary Annual Scientific Meeting of th
5 Toward Integrated and Potent Treatment for End-stage Congestive Heart Failure by Adding Cardiac Resynchronization Therapy (CRT) to Foregoing Methods(Comprehensive Treatment Centered on Biventricular Resynchronization Therapy,Plenary Session 5 (PL5) (A),
Pericardial Fluid Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Is an Indicator of Severe Myocardial Ischemia
PARP Inhibitor Can Protect against Re-Perfusion Injury after Cardioplegic Arrest
Pharmacological Assessment of Composite Arterial Conduits Using Angiography Early in the Postoperative Period
Dose Longer-Term Intravenous Administration of Atrial Natriuretic Peptide Prevent Left Ventricular Remodeling after Myocardial Infarction in Rats?
Patients Should Not Resume Smoking after Myocardial Infarction
Aortic valve replacement for aortic regurgitation in a patient with antiphospholipid antibody syndrome
Bioengineering vs Mechanical Engineering for Cardiovascular Surgery in the Next Century

もっと見る

スポンサーリンク